Jane Chang1, Lisa S Ipp2, Ariel M de Roche3, Marina Catallozzi4, Carmen Radecki Breitkopf5, Susan L Rosenthal6. 1. Department of Pediatrics, Weill Cornell Medical College/New York-Presbyterian Hospital, New York, New York. Electronic address: jac9009@med.cornell.edu. 2. Department of Pediatrics, Weill Cornell Medical College/New York-Presbyterian Hospital, New York, New York. 3. Department of Pediatrics, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York. 4. Department of Pediatrics, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York; Heilbrunn Department of Population and Family Health, Mailman School of Public Health, New York, New York. 5. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 6. Department of Pediatrics, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York; Department of Psychiatry, Columbia University College of Physicians and Surgeons/New York-Presbyterian Hospital, New York, New York.
Abstract
STUDY OBJECTIVE: To examine how adolescent-parent dyads describe decision-making regarding initiation of the human papillomavirus (HPV) vaccine series, specifically who they viewed as making the final decision. DESIGN: Semistructured interviews with adolescent-parent dyads were audio-recorded and transcribed. Responses to the question: "How did you make a decision about whether or not to receive the HPV vaccine series?" were content-coded for each individual member of the dyad. SETTING: Adolescent medicine clinics of 2 large urban medical centers and through snowball sampling. PARTICIPANTS: Adolescents 14-17 years of age and a parent (N = 262). Qualitative analyses were conducted for those who agreed that they were offered and started the HPV vaccine series (n = 109). INTERVENTIONS: None. MAIN OUTCOME MEASURES: Descriptions of the decision-making included 1 person (adolescent or parent) making the decision or joint decision-making by the adolescent and parent together. RESULTS: More than half of the dyads did not agree on who made the decision to start the vaccine. Most adolescents and parents described a similar account about when they were offered the HPV vaccine, although the interpretation of the event in terms of the decision-maker might have differed. More than half of adolescents and parents individually mentioned the health care provider in their description of the HPV vaccine decision-making process even though they were not queried about the role of the provider. CONCLUSION: Understanding the range of descriptions of these dyads is helpful to guide interventions to promote vaccine uptake in a manner that balances provider expertise, adolescent autonomy, and parental involvement.
STUDY OBJECTIVE: To examine how adolescent-parent dyads describe decision-making regarding initiation of the human papillomavirus (HPV) vaccine series, specifically who they viewed as making the final decision. DESIGN: Semistructured interviews with adolescent-parent dyads were audio-recorded and transcribed. Responses to the question: "How did you make a decision about whether or not to receive the HPV vaccine series?" were content-coded for each individual member of the dyad. SETTING: Adolescent medicine clinics of 2 large urban medical centers and through snowball sampling. PARTICIPANTS: Adolescents 14-17 years of age and a parent (N = 262). Qualitative analyses were conducted for those who agreed that they were offered and started the HPV vaccine series (n = 109). INTERVENTIONS: None. MAIN OUTCOME MEASURES: Descriptions of the decision-making included 1 person (adolescent or parent) making the decision or joint decision-making by the adolescent and parent together. RESULTS: More than half of the dyads did not agree on who made the decision to start the vaccine. Most adolescents and parents described a similar account about when they were offered the HPV vaccine, although the interpretation of the event in terms of the decision-maker might have differed. More than half of adolescents and parents individually mentioned the health care provider in their description of the HPV vaccine decision-making process even though they were not queried about the role of the provider. CONCLUSION: Understanding the range of descriptions of these dyads is helpful to guide interventions to promote vaccine uptake in a manner that balances provider expertise, adolescent autonomy, and parental involvement.
Authors: Echo L Warner; Djin Lai; Sara Carbajal-Salisbury; Luis Garza; Julia Bodson; Kathi Mooney; Deanna Kepka Journal: J Community Health Date: 2015-06
Authors: Mehwish Javaid; Dana Ashrawi; Rachel Landgren; Lori Stevens; Rosalind Bello; Lewis Foxhall; Melissa Mims; Lois Ramondetta Journal: J Community Health Date: 2017-02
Authors: Lila J Finney Rutten; Jennifer L St Sauver; Timothy J Beebe; Patrick M Wilson; Debra J Jacobson; Chun Fan; Carmen Radecki Breitkopf; Susan T Vadaparampil; Robert M Jacobson Journal: Vaccine Date: 2016-11-23 Impact factor: 3.641
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; James A Singleton Journal: MMWR Morb Mortal Wkly Rep Date: 2016-08-26 Impact factor: 17.586
Authors: Susan L Rosenthal; Ariel M de Roche; Marina Catallozzi; Carmen Radecki Breitkopf; Lisa S Ipp; Jane Chang; Jenny K R Francis; Mei-Chen Hu Journal: J Pediatr Adolesc Gynecol Date: 2016-01-25 Impact factor: 1.814
Authors: Andreia B Alexander; Nathan W Stupiansky; Mary A Ott; Debby Herbenick; Michael Reece; Gregory D Zimet Journal: BMC Pediatr Date: 2012-12-14 Impact factor: 2.125
Authors: Rachel Herman; Louise-Anne McNutt; Mehek Mehta; Daniel A Salmon; Robert A Bednarczyk; Jana Shaw Journal: Hum Vaccin Immunother Date: 2019-03-14 Impact factor: 3.452
Authors: Vita W Jongen; Maarten F Schim van der Loeff; Anders Boyd; Mariska Petrignani; Maria Prins; Marcel van der Wal; Astrid Nielen; Hester de Melker; Theo G W M Paulussen; Catharina J Alberts Journal: Hum Vaccin Immunother Date: 2020-09-23 Impact factor: 3.452